Julie Brahmer, MD
Associate Professor of Oncology
Oncology/Upper Aerodigestive Cancer Program
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Julie Brahmer, MD, MSc, FASCO: consultant/advisor/speaker: Amgen, Blueprint, Bristol-Myers Squibb, Genentech/Roche, Lilly, Janssen, Johnson & Johnson, Merck; researcher: Bristol-Myers Squibb.
Natasha Leighl, MD, MMSC, FRCPC, FASCO
Natasha Leighl, MD, FRCPC, FASCO,
Lung Site Lead, Medical Oncology
OSI Pharmaceuticals Foundation Chair
Princess Margaret Cancer Centre
Professor of Medicine, University of Toronto
Natasha Leighl, MD, MMsc, FRCPC, FASCO: researcher: Amgen, Array, AstraZeneca, Bayer, Bristol Myers Squibb, Eli Lilly, EMD Serono, Guardant Health, Inivata, MSD, Novartis, Pfizer, Roche, Takeda; consultant/advisor/ speaker: Amgen, Bristol Myers Squibb, GlaxoSmithKline, MSD, Novartis, Puma Biotechnology, Sanofi Genzyme, Takeda.
Jarushka Naidoo, MB BCH BAO, MHS
Consultant Medical Oncologist
Beaumont Hospital/RCSI University of Health Sciences
Adjunct Professor of Oncology
Sidney Kimmel Comprehensive
Johns Hopkins University
Jarushka Naidoo, MB BCH BAO, MHS: advisor: Amgen, AstraZeneca, Bristol-Myers Squibb, Merck, NGM Pharmaceuticals, Pfizer, Roche/Genentech, Takeda; data and safety monitoring board: Daiichi Sankyo.